Literature DB >> 6454524

An improved method for sacro-iliac joint imaging: a study of normal subjects, patients with sacro-iliitis and patients with low back pain.

J Ayres, A J Hilson, M N Maisey, R Laurent, G S Panayi, A J Saunders.   

Abstract

A new method is described for quantitative measurement of the uptake of 99mTc--methylene diphosphonate (MDP) by the sacro-iliac joints. The method uses 'regions of interest' providing advantages over the previously described 'slice' method; the two methods are compared in normal subjects, patients with known sacro-iliitis and patients with low back pain. Sacro-iliac activity, as calculated by the sacro-iliac index (SII) in normal patients, was shown to decrease with age in females but not in males. The SII was compared with radiographs of the sacro-iliac joints in the patients with known sacro-iliac joint disease and in those with low back pain. The method is useful for the exclusion of sacro-iliitis as a specific cause of back pain.

Entities:  

Mesh:

Year:  1981        PMID: 6454524     DOI: 10.1016/s0009-9260(81)80296-6

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  Influence of age on quantitative sacro-iliac joint imaging.

Authors:  D Dodig; S Popović; Z Domljan
Journal:  Eur J Nucl Med       Date:  1984

2.  Unilateral sacroiliac overuse syndrome in military recruits.

Authors:  R Chisin; C Milgrom; J Margulies; M Giladi; M Stein; H Kashtan; H Atlan
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-08

3.  The scintigraphy of sacroiliac joints. A comparison of 99mTc-DPD and 99mTc-MDP.

Authors:  T Lantto
Journal:  Eur J Nucl Med       Date:  1990

4.  Effect of imaging time on the values of the sacroiliac index.

Authors:  D Dodig; Z Domljan; S Popović; I Simonović
Journal:  Eur J Nucl Med       Date:  1988

Review 5.  Progress in spondylarthritis. Spondyloarthritis: lessons from imaging.

Authors:  Walter P Maksymowych
Journal:  Arthritis Res Ther       Date:  2009-05-18       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.